Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephine C McGowan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Neuropharmacology|August 19, 2017
Neurobiological Mechanisms of Stress Resilience and Implications for the Aged PopulationCharlene Faye, Josephine C Mcgowan, Christine A Denny, et al.
Frontiers in Neuroscience|May 9, 2022
Acute (<i>R,S</i>)-Ketamine Administration Induces Sex-Specific Behavioral Effects in Adolescent but Not Aged MiceAlessia Mastrodonato, Ina Pavlova, Noelle Kee, et al.
Behavioural Brain Research|September 30, 2019
Prophylactic (R,S)-ketamine selectively protects against inflammatory stressorsAlessia Mastrodonato, Omid Cohensedgh, Christina T LaGamma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 28, 2017
Prophylactic Ketamine Attenuates Learned FearJosephine C McGowan, Christina T LaGamma, Sean C Lim, et al.
The International Journal of Neuropsychopharmacology|March 1, 2022
Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged MiceAlessia Mastrodonato, Ina Pavlova, Noelle C Kee, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 31, 2018
Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stressJosephine C McGowan, Collin Hill, Alessia Mastrodonato, et al.
Fundamental & Clinical Pharmacology|July 16, 2025
Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular MechanismsMakiath Adebo, Mathilda Bonnet, Ons Laouej, et al.
Biological Psychiatry|July 18, 2021
Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive BehaviorBriana K Chen, Victor M Luna, Margaret E Shannon, et al.
Fundamental & Clinical Pharmacology|May 10, 2023
Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effectsJulie Doan, Céline Defaix, Indira Mendez-David, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
Early life stress induces social behavioral deficits and peripheral biomarker alterations in adolescence that perpetuate intergenerationallyJosephine C McGowan, Jed L Katzenstein, Natalie S Chace, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Neuropharmacology|August 19, 2017
Neurobiological Mechanisms of Stress Resilience and Implications for the Aged PopulationCharlene Faye, Josephine C Mcgowan, Christine A Denny, et al.
Frontiers in Neuroscience|May 9, 2022
Acute (<i>R,S</i>)-Ketamine Administration Induces Sex-Specific Behavioral Effects in Adolescent but Not Aged MiceAlessia Mastrodonato, Ina Pavlova, Noelle Kee, et al.
Behavioural Brain Research|September 30, 2019
Prophylactic (R,S)-ketamine selectively protects against inflammatory stressorsAlessia Mastrodonato, Omid Cohensedgh, Christina T LaGamma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 28, 2017
Prophylactic Ketamine Attenuates Learned FearJosephine C McGowan, Christina T LaGamma, Sean C Lim, et al.
The International Journal of Neuropsychopharmacology|March 1, 2022
Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged MiceAlessia Mastrodonato, Ina Pavlova, Noelle C Kee, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 31, 2018
Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stressJosephine C McGowan, Collin Hill, Alessia Mastrodonato, et al.
Fundamental & Clinical Pharmacology|July 16, 2025
Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular MechanismsMakiath Adebo, Mathilda Bonnet, Ons Laouej, et al.
Biological Psychiatry|July 18, 2021
Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive BehaviorBriana K Chen, Victor M Luna, Margaret E Shannon, et al.
Fundamental & Clinical Pharmacology|May 10, 2023
Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effectsJulie Doan, Céline Defaix, Indira Mendez-David, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
Early life stress induces social behavioral deficits and peripheral biomarker alterations in adolescence that perpetuate intergenerationallyJosephine C McGowan, Jed L Katzenstein, Natalie S Chace, et al.
Pageof 2